Sueters Jayson, Schipperheijn Rogier, Huirne Judith, Smit Theo, Guler Zeliha
Department of Gynaecology, Amsterdam UMC-Location VUmc, De Boelelaan 1117, 1105 AZ Amsterdam, The Netherlands.
Reproductive Biology Laboratory, Amsterdam UMC-Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Cells. 2025 Jan 8;14(2):76. doi: 10.3390/cells14020076.
(1) Background: For the reconstruction of a human vagina, various surgical procedures are available that are often associated with complications due to their failure to mimic the physiology of the human vagina. We recently developed a vascularized, organ-specific matrix from healthy human vaginal wall tissue with suitable biomechanical properties. A superior graft would require further extensive colonization with autologous vaginal cells to reduce complications upon implantation. However, reports on isolation of vaginal cells from biopsies are scarce, and published protocols rarely contain sufficient details. In this study, we aimed to examine protocols for inconsistencies and identify (where possible) the optimal protocol in terms of reproducibility and efficiency for isolation of human vaginal fibroblasts (FBs), epithelial cells (VECs), and smooth muscle cells (SMCs). Overall, this study aims to guide other researchers and aid future tissue engineering solutions that rely on autologous cells. (2) Methods: A total of 41 isolation protocols were tested: four protocols specific to FBs, 13 protocols for VECs, and 24 protocols for SMCs. Protocols were derived from published reports on cell isolation by enzymes, with exclusion criteria including the need for specialized equipment, surgical separation of tissue layers, or missing protocol details. Enzymatic digestion with collagenase-I, collagenase-IV, and dispase-II was used for isolation of VECs, collagenase-IV for isolation of SMCs, and collagenase-IA for isolation of FBs. Fluorescent immunostaining was applied to identify VECs with cytokeratin, SMCs with desmin, endothelial cells with UEA-1, and FBs with vimentin. Protocols were assessed based on (>95%) homogeneity, duplicate consistency, cell viability, and time to first passage. (3) Results: A total of 9 out of the 41 protocols resulted in isolation and expansion of vaginal FBs. This involved 1 out of 13 VEC protocols, 6 out of 24 SMC protocols, and 2 out of 2 FB protocols. Isolation of vaginal SMCs or VECs was not achieved. The best results were obtained after digestion with 0.1% collagenase-IV, where pure FB colonies formed with high cell viability. (4) Conclusions: Today, vaginoplasty is considered the gold standard for surgically creating a neovagina, despite its considerable drawbacks and limitations. Tissue-engineered solutions carry great potential as an alternative, but cell seeding is desired to prevent complications upon implantation of grafts. In this study, we examined isolation of human vaginal FBs, SMCs, and VECs, and identified the most efficient and reliable protocol for FBs. We further identified inconsistencies and irreproducible methods for isolation of VECs and SMCs. These findings aid the clinical translation of cell-based tissue engineering for the reconstruction and support of vaginas, fulfilling unmet medic needs.
(1) 背景:对于人类阴道重建,有多种外科手术方法,但由于未能模拟人类阴道的生理结构,这些手术常常伴有并发症。我们最近从健康的人类阴道壁组织开发出一种具有合适生物力学特性的血管化、器官特异性基质。一种优质的移植物需要用自体阴道细胞进行进一步广泛的定植,以减少植入时的并发症。然而,关于从活检组织中分离阴道细胞的报道很少,且已发表的方案很少包含足够的细节。在本研究中,我们旨在检查方案中的不一致之处,并(在可能的情况下)确定在分离人阴道成纤维细胞(FBs)、上皮细胞(VECs)和平滑肌细胞(SMCs)方面,在可重复性和效率方面的最佳方案。总体而言,本研究旨在指导其他研究人员,并有助于未来依赖自体细胞的组织工程解决方案。(2) 方法:共测试了41种分离方案:4种特定于FBs的方案、13种用于VECs的方案和24种用于SMCs的方案。这些方案源自关于酶法细胞分离的已发表报告,排除标准包括需要专门设备、组织层的手术分离或方案细节缺失。用I型胶原酶、IV型胶原酶和II型分散酶进行酶消化以分离VECs,用IV型胶原酶分离SMCs,用IA型胶原酶分离FBs。应用荧光免疫染色来鉴定表达细胞角蛋白的VECs、表达结蛋白的SMCs、表达UEA - 1的内皮细胞和表达波形蛋白的FBs。根据(>95%)同质性、重复一致性、细胞活力和首次传代时间对方案进行评估。(3) 结果:41种方案中有9种成功分离并扩增了阴道FBs。这包括13种VEC方案中的1种、24种SMC方案中的6种和2种FB方案中的2种。未实现阴道SMCs或VECs的分离。用0.1% IV型胶原酶消化后获得了最佳结果,形成了具有高细胞活力的纯FB集落。(4) 结论:如今,阴道成形术被认为是手术创建新阴道的金标准,尽管存在相当多的缺点和局限性。组织工程解决方案作为一种替代方案具有巨大潜力,但需要细胞接种以防止移植物植入时出现并发症。在本研究中,我们研究了人阴道FBs、SMCs和VECs的分离,并确定了FBs最有效和可靠的方案。我们还进一步确定了VECs和SMCs分离中不一致和不可重复的方法。这些发现有助于基于细胞的组织工程在阴道重建和支持方面的临床转化,满足未满足的医疗需求。